The Biden-Harris administration has a historic opportunity to help end HIV. New, cutting-edge drugs that prevent HIV are ...

NBA Hall of Famer Earvin “Magic” Johnson is investing in a pharmacy startup that helps clinics with high volumes of HIV ...

In June, we heard what could be this year’s biggest HIV breakthrough: a twice-yearly injection can prevent HIV infection. A ...

The second of two pivotal studies of a six-monthly HIV prevention injection containing the antiretroviral drug lenacapavir ...

IDWeek is the joint annual meeting of the Infectious Diseases Society of America, the Society for Healthcare Epidemiology of America, the HIV Medicine Association, the Pediatric Infectious Diseases ...

Following the death, the Regional HIV/AIDS Connection ... He warned they are continuing to see increasing toxicity in drugs, but for privacy reasons, he said they would not disclose what drug ...

Gilead Sciences has announced that cheaper versions of its “gamechanger” HIV prevention drug, lenacapavir, will be made available in 120 low and middle income countries. Lenacapavir is an ...

Faster access to HIV drug lenacapavir in India hinges on the waiver of local clinical trials. Six companies, including three from India, have non-exclusive, royalty-free licenses to produce generic ...

The results of the iPrEx study were released in 2010, finding that a daily dose of HIV drugs reduced the risk of HIV infection by 44% in men who have sex with men who were not living with HIV.

KARACHI: A local pharmaceutical company has reached an agreement with an American company for the manufacturing of HIV drugs. According to a notice issued to the Pakistan Stock Exchange (PSX ...

International AIDS Society, an association of HIV/AIDS professionals, applauded moves by Gilead Sciences, a biopharma company ...

which has been approved by the United States Food and Drug Administration (USFDA) for the treatment of heavily treatment-experienced adults with multidrug-resistant HIV-1 infection. Gilead ...